Navigation Links
Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent

ease progression in patients with MDS with chromosome 5q deletion. This is noteworthy because, according to the MDS Foundation, approximately 30 percent of patients diagnosed with MDS will typically progress to acute myeloid leukemia (AML). Patients receiving Revlimid also had a statistically significant overall survival advantage.

MDS, a cancer in which the bone marrow fails to make enough functioning blood cells, affects 300,000 people worldwide killing 60,000 to 70,000 a year. MDS patients suffer from anemia and fatigue and need whole-body blood transfusions as much as twice a month. Repeated transfusions can lead to a toxic buildup called "iron overload" that severely damages the heart, liver and pancreas, and patients eventually succumb to the disease.

Revlimid is indicated for the treatment of patients with transfusion- dependent anemia due to Low- or Intermediate-1-risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is also used as treatment in combination with dexamethasone for multiple myeloma patients who have received at least one prior therapy.

About H. Lee Moffitt Cancer Center & Research Institute

Located in Tampa, Florida on the University of South Florida campus, H. Lee Moffitt Cancer Center & Research Institute (www.moffitt.org) is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in U.S. News & World Report as one of America's Best Hospitals for cancer. Moffitt's sole mission is
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/5/2015)... SUNNYVALE, Calif. , May 5, 2015  Accuray ... scheduled to present at the Bank of America Merrill ... on Tuesday, May 12, 2015 at 2:20pm ... presentation will be available on the Investor Relations page ... webcast replay of the presentation will begin approximately one ...
(Date:5/5/2015)... , May 5, 2015  Image Stream Medical, a ... agreement with MedAssets, one of the largest group purchasing ... United States.  Under terms of the three-year agreement, Image ... services will be made available to MedAssets members beginning ... partnership, Image Stream Medical CEO Eddie Mitchell ...
(Date:5/5/2015)... , May 05, 2015 Research and ... the addition of the "Clinical Laboratory,Molecular Diagnostics ... 2015 to 2019 - Latin America, Africa and ... A market that just keeps on ... benefit from the explosion in biotechnology, especially genomics. ...
Breaking Medicine Technology:Image Stream Medical Announces Agreement with MedAssets 2Latin America, Africa and Middle East Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2
... VEGAS, June 28, 2011 The pharmacy made the decision ... of its customers. The fact Xpressdelivery.com offered cheapest Viagra ... of the world, and their desire to see more drugs ... was only logical. After giving the matter most careful consideration ...
... June 28, 2011 In strong collaboration with clinical ... compact version of the LokomatPro that offers greater system ... device in 2001, the LokomatPro has established itself as ... patients with neurological diseases and injuries resulting in gait ...
Cached Medicine Technology:Xpressdelivery.com Expanded Its Drug List Adding Most Demanded Generic Medications 2Hocoma Launches New Version of its Established Gait Training Device LokomatPro 2
(Date:5/5/2015)... York, New York (PRWEB) May 05, 2015 ... lawsuits ( http://www.testosteronelawsuithub.com/ ) filed on behalf ... complications due to their use of prescription ... in the federal multidistrict litigation underway in ... According to court documents dated May 1st, ...
(Date:5/5/2015)... York, NY (PRWEB) May 05, 2015 The newly ... on the experiences of Dr. Brad Reedy from his ... Judith Regan was asked why she chose to publish a parenting ... as a parent (and publisher) is the idea that it is ... we and our children are on the trek sometimes together and ...
(Date:5/5/2015)... 05, 2015 Dr. Patricia George knows ... (PH). A pulmonologist and pulmonary hypertension specialist at the ... a work event when an initial idea entered her ... sitting in the audience at the 2010 PHA International ... healthcare providers – were recalling their climb up Mt. ...
(Date:5/5/2015)... 05, 2015 " QuickPick Travel ” was ... which takes a look small, medium, and large businesses making ... NewsWatch and a business expert, conducted the business review and ... plan up to three weeks of vacation for free. , ... friends, and explore the world. And when people are preparing ...
(Date:5/5/2015)... May 05, 2015 MAP Health Management, ... revenue cycle management for addiction treatment facilities, announced today ... President of Business Development. Mr. Mooney, who has more ... field, will be responsible for developing new strategic partnerships ... MAP’s core products and new initiatives. , Prior to ...
Breaking Medicine News(10 mins):Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2
... This release is available in German . ... problem in AIDS . Shortly after an individual becomes infected ... in this organ for life. Many HIV-infected individuals experience disturbances ... dementia. How the virus causes brain disease is still unclear. ...
... Fla., March 4 Viles & Beckman,LLC revealed today ... killed or crippled by side effects, such as renal ... into patients while,undergoing open heart surgery -- Trasylol -- ... Trasylol was recalled from the US market in,November 2007 ...
... LA JOLLA, CA A nuclear receptor protein, known ... also exerts powerful anti-inflammatory effects in arteries, suppressing atherosclerosis ... to new research by scientists at the Salk Institute ... Health. , Their findings, reported in this weeks ...
... for shamans and herb women? Not at all, for many ... products or were developed on the basis of natural substances. ... made from yew trees. The popular periwinkle plant, which grows ... of vinca alkaloids that are effective, for example, against malignant ...
... Developer,s Foundation to Lead the ... Ending Global Hunger, Improving Nutrition, NEW YORK, March ... a $15 million challenge grant to transform The Hebrew,University ... in Rehovot, Israel. The gift will be the cornerstone ...
... in training have a 17 percent less chance of ... surgery at non-teaching hospitals, according to results of a ... the Annals of Thoracic Surgery. , Theres a ... because of training issues, and concerns are frequently voiced ...
Cached Medicine News:Health News:Neural progenitor cells as reservoirs for HIV in the brain 2Health News:Drug Risk Harms 10,000+ Floridians 2Health News:New potential drug target for the treatment of atherosclerosis 2Health News:New potential drug target for the treatment of atherosclerosis 3Health News:Screening the herbal pharmacy 2Health News:Robert H. Smith 'Feeding the Future' with $15 Million Gift to Hebrew University of Jerusalem 2Health News:Risk of surgery for lung cancer lower at teaching hospitals 2
... Analyzer (PCA) is used in conjunction ... a variety of parameters in whole ... 50 patient records and permits on-screen ... as transmission of records to a ...
... images and patient information from all ... in one central system. It simplifies ... cost-effectiveness so that healthcare professionals can ... helping people., ,Many Sources, One Solution ...
... The Attain 4194 Bipolar over-the-wire left-heart lead ... This new steroid-eluting lead has an angled ... a guidewire or a stylet delivery method, ... maneuver and position the lead in a ...
... Our Maxenon Xi300 is so bright many ... have higher gears to shift into when the ... features such as a true Hot Start and ... 300-watt xenon system that prevent failed start ups ...
Medicine Products: